These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 10870114

  • 1. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
    Lech-Maranda E, Korycka A, Robak T.
    Haematologica; 2000 Jun; 85(6):588-94. PubMed ID: 10870114
    [Abstract] [Full Text] [Related]

  • 2. Influence of gemcitabine (2',2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro.
    Lech-Marańda E, Korycka A, Robak T.
    Eur J Haematol; 2000 Nov; 65(5):317-21. PubMed ID: 11092462
    [Abstract] [Full Text] [Related]

  • 3. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Marañda E, Szmigielska A, Robak T.
    Cancer Invest; 1999 Nov; 17(2):95-101. PubMed ID: 10071592
    [Abstract] [Full Text] [Related]

  • 4. Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders.
    Santini V, Bernabei A, Gozzini A, Scappini B, Zoccolante A, D'Ippolito G, Figuccia M, Ferrini PR.
    Haematologica; 1997 Nov; 82(1):11-5. PubMed ID: 9172997
    [Abstract] [Full Text] [Related]

  • 5. Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.
    Bouffard DY, Momparler LF, Momparler RL.
    Anticancer Drugs; 1991 Feb; 2(1):49-55. PubMed ID: 1958852
    [Abstract] [Full Text] [Related]

  • 6. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Bergman AM, Pinedo HM, Jongsma AP, Brouwer M, Ruiz van Haperen VW, Veerman G, Leyva A, Eriksson S, Peters GJ.
    Biochem Pharmacol; 1999 Feb 15; 57(4):397-406. PubMed ID: 9933028
    [Abstract] [Full Text] [Related]

  • 7. Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells.
    Bhalla K, Holladay C, Lutzky J, Ibrado AM, Bullock G, Jasiok M, Singh S.
    Gynecol Oncol; 1992 Apr 15; 45(1):32-9. PubMed ID: 1601333
    [Abstract] [Full Text] [Related]

  • 8. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
    Korycka A, Robak T.
    Arch Immunol Ther Exp (Warsz); 2003 Apr 15; 51(1):61-7. PubMed ID: 12691305
    [Abstract] [Full Text] [Related]

  • 9. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
    Bergman AM, Munch-Petersen B, Jensen PB, Sehested M, Veerman G, Voorn DA, Smid K, Pinedo HM, Peters GJ.
    Biochem Pharmacol; 2001 Jun 01; 61(11):1401-8. PubMed ID: 11331076
    [Abstract] [Full Text] [Related]

  • 10. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.
    Marley SB, Davidson RJ, Goldman JM, Gordon MY.
    Leukemia; 2000 Aug 01; 14(8):1396-400. PubMed ID: 10942234
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine.
    Heinemann V, Hertel LW, Grindey GB, Plunkett W.
    Cancer Res; 1988 Jul 15; 48(14):4024-31. PubMed ID: 3383195
    [Abstract] [Full Text] [Related]

  • 12. Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells.
    Ross DD, Cuddy DP.
    Biochem Pharmacol; 1994 Oct 18; 48(8):1619-30. PubMed ID: 7980627
    [Abstract] [Full Text] [Related]

  • 13. [Non-clinical studies of gemcitabine--the mode of action and antitumor activities].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1999 Feb 18; 26(3):393-400. PubMed ID: 10065109
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
    Csoka K, Liliemark J, Larsson R, Nygren P.
    Semin Oncol; 1995 Aug 18; 22(4 Suppl 11):47-53. PubMed ID: 7481845
    [Abstract] [Full Text] [Related]

  • 15. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
    Korycka A, Robak T.
    Leuk Lymphoma; 2003 Sep 18; 44(9):1549-55. PubMed ID: 14565659
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation.
    Vrana JA, Kramer LB, Saunders AM, Zhang XF, Dent P, Povirk LF, Grant S.
    Biochem Pharmacol; 1999 Jul 01; 58(1):121-31. PubMed ID: 10403525
    [Abstract] [Full Text] [Related]

  • 17. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan 01; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 18. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
    Bhalla K, MacLaughlin W, Cole J, Arlin Z, Baker M, Graham G, Grant S.
    Blood; 1987 Aug 01; 70(2):568-71. PubMed ID: 3607288
    [Abstract] [Full Text] [Related]

  • 19. The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro.
    Korycka A, Smolewski P, Robak T.
    Eur J Haematol; 2004 Dec 01; 73(6):418-26. PubMed ID: 15522064
    [Abstract] [Full Text] [Related]

  • 20. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
    Jiang HY, Hickey RJ, Abdel-Aziz W, Malkas LH.
    Cancer Chemother Pharmacol; 2000 Dec 01; 45(4):320-8. PubMed ID: 10755321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.